Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss BILL Q1 2026 Earnings EPS Surprises to the Upside Stock Declines Despite Beat PSIX Q1 2026 Earnings EPS Falls Short of Estimates by Over 52 TFX Q1 2026 Earnings Earnings Beat Drives Modest Share Gain Jiayin Group Inc Q4 2024 Earnings EPS of 523 Reported Stock Declines 87 PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines